Issued Patents 2020
Showing 1–4 of 4 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10697970 | S100A9 levels for predicting lenalidomide and erythropoietin responsiveness | — | 2020-06-30 |
| 10688077 | Inflammasome activation in myelodysplastic syndromes | Sheng Wei | 2020-06-23 |
| 10682417 | Targeted sensitization of non-del(5q) malignant cells | Sheng Wei | 2020-06-16 |
| 10612097 | RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS | — | 2020-04-07 |